Marathon Capital Management Ishares Biotechnology ETF Transaction History

Marathon Capital Management

$407 Million
Q1 2024

A detailed history of Marathon Capital Management transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Marathon Capital Management holds 3,615 shares of IBB stock, worth $520,632. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,615

Previous 3,615 -0.0%

Holding current value

$520,632

Previous $491,000 1.02%

% of portfolio

0.12%

Previous 0.13%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$122.27 - $131.47 $24,454 - $26,294	-200 Reduced 5.24%	3,615 $442,000
Q2 2023 Aug 14, 2023	SELL	$125.53 - $133.58 $12,553 - $13,358	-100 Reduced 2.55%	3,815 $484,000
Q1 2023 May 12, 2023	SELL	$121.97 - $137.23 $24,394 - $27,445	-200 Reduced 4.86%	3,915 $505,000
Q4 2022 Feb 14, 2023	BUY	$127.27 - $138.43 $12,727 - $13,843	100 Added 2.49%	4,115 $540,000
Q3 2022 Nov 14, 2022	BUY	N/A	4,015 New	4,015 $470,000

Q1 2022 May 13, 2022	SELL	N/A	-3,715 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	N/A	-600 Reduced 13.9%	3,715 $567,000
Q3 2021 Nov 15, 2021	SELL	N/A	-500 Reduced 10.38%	4,315 $698,000
Q4 2020 Feb 08, 2021	SELL	N/A	-100 Reduced 2.03%	4,815 $729,000
Q2 2020 Aug 14, 2020	BUY	N/A	4,915 New	4,915 $672,000

Others Institutions Holding IBB

# of Institutions

989

Shares Held

37.9M

Call Options Held

1.81M

Put Options Held

8.71M

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Ishares Biotechnology ETF Transaction History